论文部分内容阅读
三七冠心宁是从五加科植物三七(Panaxnotoginseng (Both)P,H,Chen)中提制出的一种新药,主要含四环三萜达马烷型皂甙,还有黄醇类及甾醇类化合物,其中主要含有人参皂甙R_(a1),R_(b1),三七皂试D_1等,药理实验初步研究的结果,证明该药具有扩张冠状动脉,增加冠脉血流量,减慢心率,降低主动脉压和外周血管阻力,降低心肌耗氧量和增加营养性心肌血流量,临床经全国28个医院828例临床验证,其中778例有心绞痛患者,治疗后总有效率为70.2％,显效率为20.1％,625例患者心电图改善者为34.8％,显效率14.2％。但三七冠心宁对血浆
Panaxnotoginseng (Both) P, H, Chen) is a new drug derived from Panaxnotoginseng (Both) Pseudomonas aeruginosa. It mainly contains tetracyclic triterpenoid saponin, And sterols, which mainly contain ginsenosides R_ (a1), R_ (b1), notoginseng soap test D_1 and so on, the preliminary results of pharmacological experiments show that the drug has the dilatation of coronary arteries, increase coronary blood flow, slow down Heart rate, reduce the aortic pressure and peripheral vascular resistance, reduce myocardial oxygen consumption and increase the nutrition of myocardial blood flow, clinically 828 clinical trials in 28 hospitals across the country, of which 778 cases of angina patients after treatment, the total effective rate was 70.2% , Markedly effective rate was 20.1%, 625 patients improved electrocardiogram was 34.8%, markedly effective rate of 14.2%. But Panax Corning on plasma